Change in HbA1c associated with treatment intensification among patients with type 2 diabetes and poor glycemic control
Author:
Affiliation:
1. Georgetown University Medical Center, Washington, DC, USA;
2. AstraZeneca Pharmaceuticals LP, Fort Washington, PA, USA at the time the research was conducted;
3. Janssen Scientific Affairs LLC, Titusville, NJ, USA
Funder
AstraZeneca Pharmaceuticals
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1292231
Reference22 articles.
1. Impact of concurrent macrovascular co-morbidities on healthcare utilization in patients with type 2 diabetes in Europe: a matched study
2. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
3. Microvascular and Macrovascular Complications of Diabetes
4. Marginal differences in health-related quality of life of diabetic patients with and without macrovascular comorbid conditions in the United States
5. AACE/ACE Comprehensive Diabetes Management Algorithm 2015
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combination of retagliptin and henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, active‐controlled, phase 3 trial;Diabetes, Obesity and Metabolism;2024-04-15
2. Effect of treatment intensification on glycemic control in patients with subcontrolled type 2 diabetes who failed on two oral antidiabetic agents;Diabetes Epidemiology and Management;2023-01
3. Predictors of success and failure in achieving glycemic control targets in patients with type 2 diabetes on basal insulin: review of the real-world evidence studies;Diabetes mellitus;2022-12-28
4. Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER study;Diabetes Research and Clinical Practice;2021-08
5. Delays in Insulin Initiation among Patients with Type 2 Diabetes Mellitus in Southeast China: A Retrospective, Real-World Study;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2020-08
Delays in Insulin Initiation among Patients with Type 2 Diabetes Mellitus in Southeast China: A Retrospective, Real-World Study
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3